English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Risk factors for the development of a first episode of Pneumocystis carinii pneumonia (PCP) were investigated in the Adult and Adolescent Spectrum of Disease Project, a medical record review study involving longitudinal follow-up of human immunodeficiency virus-infected adults in 9 US cities. Risk factors included decreasing CD4 lymphocyte count and history of AIDS-defining illness, non-P. carinii pneumonia, oral thrush, or unexplained fever for &gt; or = 2 days; PCP prophylaxis was protective. PCP incidence/100 person-years of observation among persons not prescribed PCP prophylaxis was higher in those with CD4 lymphocyte counts &lt; 250 cells/microL or CD4 cell percent &lt; 14% (8.3; 95% confidence interval [CI], 7.7-9.0) than in persons with CD4 cell counts &lt; 200 or history of thrush or fever, which constitute current criteria for prophylaxis against PCP (5.9; 95% CI, 5.5-6.4). Because of increased efficiency in capturing persons at highest risk, CD4 cell count &lt; 250 or CD4 cell percent &lt; 14% should be considered as criteria for prophylaxis against first episodes of PCP.

the journal of infectious diseases (online. university of chicago press)/the journal of infectious diseases

Risk Factors for Primary<i>Pneumocystis carinii</i>Pneumonia in Human Immunodeficiency Virus‐Infected Adolescents and Adults in the United States: Reassessment of Indications for Chemoprophylaxis

Risk Factors for PrimaryPneumocystis cariniiPneumonia in Human Immunodeficiency Virus‐Infected Adolescents and Adults in the United States: Reassessment of Indications for Chemoprophylaxis